Cargando…
Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
ABSTRACT: Generalized severe epidermolysis bullosa simplex (EBS-gen sev) is caused by mutations within either the KRT5 or KRT14 gene, phenotypically resulting in blistering and wounding of the skin and mucous membranes after minor mechanical friction. In a clinical phase 2/3 trial, diacerein has rec...
Autores principales: | Ablinger, Michael, Felder, Thomas K., Wimmer, Monika, Zauner, Roland, Hofbauer, Peter, Lettner, Thomas, Wolkersdorfer, Martin, Lagler, Florian B., Diem, Anja, Bauer, Johann W., Wally, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211505/ https://www.ncbi.nlm.nih.gov/pubmed/30382914 http://dx.doi.org/10.1186/s13023-018-0940-1 |
Ejemplares similares
-
Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study
por: Wally, Verena, et al.
Publicado: (2013) -
MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex
por: Lettner, Thomas, et al.
Publicado: (2013) -
Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis
por: Brunner, Susanne M., et al.
Publicado: (2023) -
5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022) -
An ex vivo
RNA
trans‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex
por: Peking, P., et al.
Publicado: (2018)